You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Detrusor Overactivity

Showing 1 - 25 of 350
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urodynamic Exam, Neurologic Disorder Trial in Paris (urodynamic exam in sitting and lying position)

Not yet recruiting
  • Urodynamic Exam
  • Neurologic Disorder
  • urodynamic exam in sitting and lying position
  • Paris, France
    Physical and Rehabilitation Medicine Pitié Salpêtrière Hospital
Jul 24, 2023

Urinary Bladder, Overactive, Urodynamics, Effect of Drug Trial in Taipei (Intradetrusor Botox® (onabotulinumtoxinA) injection,

Recruiting
  • Urinary Bladder, Overactive
  • +2 more
  • Intradetrusor Botox® (onabotulinumtoxinA) injection
  • Combine Mirabegron and Solifenacin.
  • Taipei, Taiwan
    Mackay Memorial Hospital
Jul 29, 2023

Neurogenic Detrusor Overactivity Trial in Worldwide (mirabegron)

Not yet recruiting
  • Neurogenic Detrusor Overactivity
  • Palo Alto, California
  • +11 more
Jan 16, 2023

Neurogenic Detrusor Overactivity Trial (Vibegron)

Not yet recruiting
  • Neurogenic Detrusor Overactivity
  • (no location specified)
Aug 4, 2022

Spinal Cord Injuries, Neurogenic Bladder, Neurogenic Detrusor Overactivity Trial (Neuromodulation)

Not yet recruiting
  • Spinal Cord Injuries
  • +3 more
  • Neuromodulation
  • (no location specified)
Aug 12, 2022

Triggered Sacral Neuromodulation for Neurogenic Bladder

Recruiting
  • Urinary Incontinence
  • Urinary Bladder, Neurogenic
  • UroMonitor
  • ASCU
  • Cleveland, Ohio
    Louis Stokes VA Medical Center, Cleveland, OH
Nov 15, 2022

Neurogenic Detrusor Overactivity Trial in Colombia, United States (Darifenacin)

Terminated
Has Results
  • Neurogenic Detrusor Overactivity
  • San Diego, California
  • +11 more
May 13, 2022

Neurogenic Bladder, Lower Urinary Tract Symptoms, Overactive Bladder Trial (Standard number of injection sites, Reduced number

Not yet recruiting
  • Neurogenic Bladder
  • +4 more
  • Standard number of injection sites
  • Reduced number of injection sites
  • (no location specified)
Sep 22, 2023

Spinal Cord Injuries, Urinary Bladder, Overactive Trial in Nesoddtangen, Oslo (Onabotulinumtoxin A, Placebo)

Completed
  • Spinal Cord Injuries
  • Urinary Bladder, Overactive
  • Onabotulinumtoxin A
  • Placebo
  • Nesoddtangen, Norway
  • +1 more
Nov 22, 2022

Developing a Simple Test to Diagnose Overactive Bladder

Not yet recruiting
  • Overactive Bladder
  • +2 more
  • Urodynamics aka filling cystometry
  • (no location specified)
Oct 7, 2022

Neurogenic Detrusor Overactivity Trial in Worldwide (Mirabegron)

Completed
Has Results
  • Neurogenic Detrusor Overactivity
  • Randwick, New South Wales, Australia
  • +31 more
Sep 21, 2022

USI and/or DO in Cystocele Before and After Cystocele Repair

Completed
  • Urodynamic Stress Incontinence
  • Detrusor Overactivity
  • Cystocele repair
  • Taipei, Taiwan
    National Taiwan University Hospital
Jul 20, 2021

Overactive Bladder, Neurogenic Detrusor Overactivity Trial in Aalborg, Aarhus, Warsaw (mirabegron)

Completed
  • Overactive Bladder
  • Neurogenic Detrusor Overactivity
  • Aalborg, Denmark
  • +2 more
Jun 28, 2021

BO and DO in Cystocele Before and After Cystocele Repair

Completed
  • Bladder Oversensitivity
  • Detrusor, Overactive
  • Cystocele repair
  • Taipei, Taiwan
    National Taiwan University Hospital
Jul 20, 2021

Urinary Bladder, Overactive Trial in Japan (GSK1358820, Placebo)

Completed
Has Results
  • Urinary Bladder, Overactive
  • Aomori, Japan
  • +8 more
Jul 13, 2021

Neurogenic Detrusor Overactivity, Overactive Bladder, Pharmacokinetics of Mirabegron Trial in Worldwide (Mirabegron)

Completed
  • Neurogenic Detrusor Overactivity
  • +2 more
  • Edegem, Belgium
  • +12 more
Jul 13, 2021

Spinal Cord Injury, Acute Trial in Switzerland (VERUM TTNS, SHAM TTNS)

Recruiting
  • Spinal Cord Injury, Acute
  • VERUM TTNS
  • SHAM TTNS
  • Basel, Switzerland
  • +3 more
Oct 21, 2022

Neurogenic Detrusor Overactivity Trial in Worldwide (Rec 0/0438 1 mg or Rec 0/0438 2 mg, )

Completed
  • Neurogenic Detrusor Overactivity
  • Rec 0/0438 1 mg or Rec 0/0438 2 mg
  • placebo
  • Praha, Czechia
  • +8 more
Jan 26, 2021

Urinary Bladder, Neurogenic Trial in Japan (Fesoterodine PR 4 mg, Fesoterodine PR 8 mg, Fesoterodine BIC 2 mg)

Completed
Has Results
  • Urinary Bladder, Neurogenic
  • Fesoterodine PR 4 mg
  • +3 more
  • Obu, Aichi, Japan
  • +6 more
Nov 25, 2020

Portable Bladder Scanner to Determine Age/ Volume Specific

Completed
  • Neurogenic Bladder
  • +2 more
  • Bladder scan
  • Seoul, Korea, Republic of
    Seoul National University Hospital
May 11, 2021

Overactive Bladder Trial in Saint-Petersburg (Transvertebral magnetic stimulation)

Recruiting
  • Overactive Bladder
  • Transvertebral magnetic stimulation
  • Saint-Petersburg, Russian Federation
    Joint-Stock Company "North-Western Centre of Evidence-Based Medi
Oct 1, 2020

Neurogenic Urinary Bladder, Neurogenic Bladder Disorder, Neurogenic Dysfunction of the Urinary Bladder Trial in Murnau,

Terminated
  • Neurogenic Urinary Bladder
  • +4 more
  • Murnau, Germany
  • +2 more
Dec 11, 2020

Overactive Bladder, Overactive Detrusor, Overactive Bladder Syndrome Trial in Cambridge (Bicarbonate protocol, Standard

Recruiting
  • Overactive Bladder
  • +4 more
  • Bicarbonate protocol
  • Standard protocol
  • Cambridge, Massachusetts
    Boston Urogynecology Associates
Mar 1, 2022

Detrusor Muscle Hyperactivity Trial in Worldwide (Botulinum toxin type A, Placebo)

Completed
Has Results
  • Detrusor Muscle Hyperactivity
  • Botulinum toxin type A
  • Placebo
  • Praha, Czechia
  • +16 more
Nov 4, 2020

Neurogenic Detrusor Overactivity Trial in Brussels (4 mg Fesoterodine ER tablet from Zwickau, 4 mg fesoterodine ER tablet from

Completed
  • Neurogenic Detrusor Overactivity
  • 4 mg Fesoterodine ER tablet from Zwickau
  • +3 more
  • Brussels, Bruxelles-capitale, Région DE, Belgium
    Brussels Clinical Research Unit
May 6, 2021